Based on a 70-kilogram individual, Herceptin will cost on average of about $2,700 per cycle every three weeks until the disease worsens, not until the tumour stops growing, as previously reported.

The breast cancer drug Herceptin has been approved for use on the NHS, under draft guidance issued by the Government's health watchdog today. The National Institute for Health and Clinical ...

Herceptin is thought to block instructions for the tumour cell to divide and signals immune cells to destroy the cancer. In May 2005, three large-scale studies of the drug were abruptly halted ...

Herceptin, an intravenous therapy, costs between $35,000 and $45,000 a year, depending on the patient's weight.

Herceptin is already approved for the later stages of the disease. The news was welcomed by women who have had to fight to be prescribed the drug, which costs £20,000 a year per patient. Barbara ...

“Over the past 20 years, Herceptin has significantly advanced treatment of HER2-positive breast cancer,” said Sandra Horning, MD, chief medical officer and head of Global Product Development ...